- Home
- NXTC vs ZOOZ Comparison
NXTC vs ZOOZ Comparison
Compare NXTC & ZOOZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXTC
- ZOOZ
- Stock Information
- Founded
- NXTC 2015
- ZOOZ 2013
- Country
- NXTC United States
- ZOOZ Israel
- Employees
- NXTC N/A
- ZOOZ N/A
- Industry
- NXTC Biotechnology: Pharmaceutical Preparations
- ZOOZ
- Sector
- NXTC Health Care
- ZOOZ
- Exchange
- NXTC Nasdaq
- ZOOZ NYSE
- Market Cap
- NXTC 31.6M
- ZOOZ 34.7M
- IPO Year
- NXTC 2019
- ZOOZ N/A
- Fundamental
- Price
- NXTC $0.89
- ZOOZ $2.87
- Analyst Decision
- NXTC Strong Buy
- ZOOZ Strong Buy
- Analyst Count
- NXTC 2
- ZOOZ 1
- Target Price
- NXTC $4.00
- ZOOZ $5.00
- AVG Volume (30 Days)
- NXTC 218.5K
- ZOOZ 11.1K
- Earning Date
- NXTC 11-07-2024
- ZOOZ 02-16-2025
- Dividend Yield
- NXTC N/A
- ZOOZ N/A
- EPS Growth
- NXTC N/A
- ZOOZ N/A
- EPS
- NXTC N/A
- ZOOZ N/A
- Revenue
- NXTC N/A
- ZOOZ $506,656.00
- Revenue This Year
- NXTC N/A
- ZOOZ N/A
- Revenue Next Year
- NXTC N/A
- ZOOZ $37.50
- P/E Ratio
- NXTC N/A
- ZOOZ N/A
- Revenue Growth
- NXTC N/A
- ZOOZ N/A
- 52 Week Low
- NXTC $0.87
- ZOOZ $1.66
- 52 Week High
- NXTC $2.57
- ZOOZ $4.60
- Technical
- Relative Strength Index (RSI)
- NXTC 22.88
- ZOOZ N/A
- Support Level
- NXTC $1.06
- ZOOZ N/A
- Resistance Level
- NXTC $1.21
- ZOOZ N/A
- Average True Range (ATR)
- NXTC 0.10
- ZOOZ 0.00
- MACD
- NXTC -0.02
- ZOOZ 0.00
- Stochastic Oscillator
- NXTC 5.21
- ZOOZ 0.00
About NXTC NextCure Inc.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases, and NC181, for Alzheimer's disease.
About ZOOZ ZOOZ POWER LTD
Zooz Power Ltd is a provider of Flywheel-based Power Boosting solutions enabling widespread deployment of ultra-fast charging infrastructure for electric vehicles (EV) while overcoming existing grid limitations. ZOOZ pioneers its flywheel-based power boosting technology, enabling efficient utilization and power management of a power-limited grid at an EV charging site. Its Flywheel technology allows high-performance, reliable, and cost-effective ultra-fast charging infrastructure. ZOOZ Power's sustainable, power-boosting solutions are built with longevity and the environment in mind, helping its customers and partners accelerate the deployment of fast-charging infrastructure, thus facilitating improved utilization rates, efficiency, and greater flexibility.